| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 0 | 12.941 | 32.998 | 57.391 | 60.019 | 83.460 |
| Total Income - EUR | - | - | - | - | 0 | 12.941 | 32.998 | 57.763 | 61.287 | 86.645 |
| Total Expenses - EUR | - | - | - | - | 28 | 302 | 9.428 | 6.421 | 12.919 | 30.512 |
| Gross Profit/Loss - EUR | - | - | - | - | -28 | 12.639 | 23.570 | 51.342 | 48.368 | 56.132 |
| Net Profit/Loss - EUR | - | - | - | - | -28 | 12.278 | 22.693 | 49.999 | 47.847 | 53.125 |
| Employees | - | - | - | - | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Ob-Gyn Performance S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 77 | 0 | 10.365 | 6.251 | 17.544 | 10.940 |
| Current Assets | - | - | - | - | 85 | 12.532 | 19.103 | 44.014 | 47.265 | 108.236 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 0 | 521 | 0 | 35.533 | -5.068 | 554 |
| Cash | - | - | - | - | 85 | 12.011 | 19.103 | 8.481 | 52.333 | 107.682 |
| Shareholders Funds | - | - | - | - | 15 | 12.292 | 29.053 | 50.044 | 62.344 | 115.121 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 148 | 239 | 415 | 221 | 2.464 | 4.055 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Ob-Gyn Performance S.r.l.